U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.

Sanofi ( ($SNY) ) just unveiled an update. In December 2025, Sanofi announced the completion of its acquisition of Vicebio Ltd, which enhances its ...

Sanofi (NASDAQ:SNY) is a French pharmaceutical firm that has been at the center of several analysts’ attention lately.

China’s National Medical Products Administration (NMPA) has granted approval for Sanofi’s rare haematologic disease ...

Eli Lilly shares rose after the drug giant said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, significantly ...

Sanofi secures China approvals for Qfitlia and Cablivi, expanding its rare hematology portfolio with new options for ...

Federal officials say the U.S. Food and Drug Administration (FDA) is reviewing reports of possible deaths in adults and ...

GlobalCapital presents the nominations for its Syndicated Loan, Leveraged Finance and Private Debt Awards 2025. The Awards, ...

After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the ...

Paramount launches a $108 billion hostile bid for Warner Bros., raising questions about major takeovers and industry impact.

Gemini Space Station, a cryptocurrency company founded by Cameron and Tyler Winklevoss, said that its affiliate Gemini Titan has received a designated contract market license. Amazon Expands Same-Day ...

Sanofi (SNY) has received Chinese regulatory approval for two rare hematology drugs, Qfitlia and Cablivi, significantly ...